Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in Angiosarcoma
NCT04518124Phase 2Completed
- Sponsor
- Netherlands Cancer Institute
- Start
- Dec 2019
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in angiosarcoma, sponsored by Netherlands Cancer Institute. Started Dec 2019; status: completed.
02
Drugs
propranolol
03
Conditions
angiosarcoma
Beyond the preview
Go deeper on NCT04518124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04518124.